6 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Treatment of with Community-Acquired ... fluoroquinolone #IDSA ... #Community #Acquired ... #Pneumonia #Antibiotics ... #Guidelines #pharmacology
Antibiotics for severe community-onset pneumonia 

Atypical coverage always 

- Usually azithromycin 500 mg daily 

- Doxycycline
severe community-onset ... Vancomycin #Community ... #Acquired #Pneumonia ... #CAP #Antibiotics ... #Coverage #Management
Antibiotic treatment durations for first line antibiotics recommended by Public Health England (PHE) guidance
 • Acute
acquired pneumonia ... acquired pneumonia ... #management #durations ... #primarycare #outpatient ... #treatment #pharmacology
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
anidulafungin; CAS ... fluconazole; ISA ... #Antifungal #antibiogram ... #management #pharmacology ... #spectrum #coverage
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Community Acquired ... Diagnosis and Management ... 96.1% • Empiric antibiotic ... MRSA: Add MRSA coverage ... #Diagnosis #Management
For my UME micro course, I made a figure that captures this terminology and lets learners
‘broaden’ this coverage ... We can combine these ... #coverage #antibiogram ... #pharmacology # ... management #spectrum